Impaired glomerular and tubular function as a short-term effect of sirolimus treatment in the rat

American Journal of Nephrology

Volumn 25, Issue 4, 2005, Pages 411-416

  Nielsen, Finn Thomsen ^a   Starklint, Henrik ^a   Dieperink, Hans ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Blood pressure; Glomerular filtration rate; Immunosuppression; Lithium clearance; Nephrotoxicity; Renal morphology; Renal tubular function; Sirolimus

Indexed keywords

CALCINEURIN INHIBITOR; INULIN; LITHIUM; RAPAMYCIN; SODIUM;

ALLOTRANSPLANTATION; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; AUTOPSY; BLOOD PRESSURE; BODY WEIGHT; CATHETERIZATION; CONTROLLED STUDY; DRUG CLEARANCE; DRUG EFFECT; FOOD INTAKE; GLOMERULAR DYSFUNCTION; GLOMERULUS FILTRATION RATE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY; KIDNEY CLEARANCE; KIDNEY FUNCTION; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ABSORPTION; MALE; MORPHOLOGY; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SHORT COURSE THERAPY; SKIN ALLOGRAFT; TUBULAR DYSFUNCTION; WEIGHT GAIN;

ANIMALS; BLOOD PRESSURE; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY GLOMERULUS; KIDNEY TUBULES; MALE; MODELS, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; SIROLIMUS; SKIN TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 23844496122     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087275     Document Type: Article

References (18)

1. DiJoseph JF, Sharma RN, Chang JY: The effect of rapamycin on the kidney function in the Sprague-Dawley rat. Transplantation 1992;53:507-513.
2. Thliveris JA, Yatscoff RW: Effect of rapamycin on morphological and functional parameters in the kidney of the rabbit. Transplantation 1995;59:427-429.
3. Kahan BD, Julian BA, Pescovitz MD, Vanrenterghem Y, Neylan J: Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in Caucasian recipients of mismatched primary renal allografts: a phase II trial. Transplantation 1999;68:1526-1532.
4. Baboolal K: A Phase III prospective, randomised study to evaluate concentration-controlled sirolimus (rapamune) with cyclosporine dose minimization or elimination at six months in de novo renal allograft recipients. Transplantation 2003;75:1404-1408.
5. Kreis H, Cisterne J-M, Land W, Wramner L, Squifflet J-P, Abramowicz D, Campistol JM, Morales J-M, Grinyo J-M, Mourad G, Berthoux F-C, Brattström C, Lebranchu Y, Vialtel P for the Sirolimus European Renal Transplant Study Group: Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients. Transplantation 2000;69:1252-1260.
6. Morales JM, Wramner L, Kreis H, Durand D, Campistol JM, Andres A, Arenas J, Nègre E, Burke JT, Groth CG for the Sirolimus European Renal Transplant Study Group: Sirolimus does not exhibit nephrotoxicity compared to cyclosporine in renal transplant recipients. Am J Transplant 2002;2:436-442.
7. Ninova D, Covarrubias M, Rea DJ, Park WD, Grande J, Stegall MD: Acute nephrotoxicity of tacrolimus and sirolimus in renal isografts: differential intragraft expression of transforming growth factor-β1 and α-smooth muscle actin. Transplantation 2004;78:338-344.
8. Fuller TF, Freise CE, Serkova N, Niemann CU, Olson JL, Feng S: Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury. Transplantation 2003;76:1594-1599.
9. Andoh TF, Burdmann EA, Fransechini N, Houghton DC, Bennett WM: Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506. Kidney Int 1996;50:1110-1117.
10. Nielsen FT, Ottosen P, Starklint H, Dieperink H: Kidney function and morphology after short-term combination therapy with cyclosporine A, tacrolimus and sirolimus in the rat. Nephrol Dial Transplant 2003;18:491-496.
11. Waller JR, Murphy GJ, Bicknell GR, Toomey D, Nicholson ML: Effects of the combination of rapamycin with tacrolimus or cyclosporine on experimental intimal hyperplasia. Br J Surg 2002;89:1390-1395.
12. Smith KD, Wrenshall LE, Nicosia RF, Pichler R, Marsh CL, Alpers CE, Polissar N, Davis CL: Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use. J Am Soc Nephrol 2003;14:1037-1045.
13. Lo A, Egidi MF, Gaber LW, Shokouh-Amiri MH, Nazakatgoo N, Fisher JS, Gaber AO: Observations regarding the use of sirolimus and tacrolimus in high-risk cadaveric renal transplantation. Clin Transplant 2004;18:53-61.
14. Dieperink H, Leyssac PP, Starklint H, Kemp E: Long-term cyclosporine nephrotoxicity in the rat: effects on renal function and morphology. Nephrol Dial Transplant 1988;3:317-326.
15. Nielsen FT, Leyssac PP, Kemp E, Starklint H, Dieperink H: Nephrotoxicity of FK506 in the rat: studies on glomerular and tubular function, and on the relationship between efficacy and toxicity. Nephrol Dial Transplant 1995; 10:334-340.
16. Thomsen K, Holstein-Rathlou NH, Leyssac PP: Comparison of three measures of proximal tubular reabsorption: lithium clearance, occlusion time, and micropuncture. Am J Physiol 1981;241:F348-F355.
17. Golbækdal K, Nielsen CB, Djurhuus JC, Pedersen EB: Effects of rapamycin on renal haemodynamics, water and sodium excretion, and plasma levels of angiotensin II, aldosterone, atrial natriuretic peptide, and vasopressin in pigs. Transplantation 1994;58:1153-1157.
18. Ruiz JC, Campistol JM, Grinyo JM, Mota A, Prats D, Gutiérrez JA, Hendriques AC, Pinto JR, Garcia J, Morales JM, Gómez JM, Arias M: Early cyclosporine A withdrawal in kidney-transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions. Transplantation 2004;78:1312-1318.